Immuron Ltd Files September 2024 6-K Report

Ticker: IMRN · Form: 6-K · Filed: Sep 26, 2024 · CIK: 1660046

Immuron LTD 6-K Filing Summary
FieldDetail
CompanyImmuron LTD (IMRN)
Form Type6-K
Filed DateSep 26, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, regulatory-filing

Related Tickers: IMRN

TL;DR

Immuron Ltd (IMRN) filed its September 6-K, no 12g3-2(b) info, just standard foreign issuer update.

AI Summary

Immuron Limited filed a Form 6-K on September 26, 2024, reporting its activities for the month of September 2024. The filing indicates that the company is a foreign private issuer and is not furnishing information under Rule 12g3-2(b).

Why It Matters

This filing provides an update on Immuron Limited's regulatory disclosures for September 2024, which is important for investors tracking the company's compliance and reporting status.

Risk Assessment

Risk Level: low — This filing is a routine report of foreign private issuer activities and does not contain material financial or operational news.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is filed by foreign private issuers to report information that they have made or are required to make public in their home country, or that they have filed or are required to file with a stock exchange on which they are listed.

Is Immuron Limited furnishing information under Rule 12g3-2(b)?

No, the filing explicitly states 'No' next to the indication for Rule 12g3-2(b).

What is the SEC file number for Immuron Limited?

The SEC file number for Immuron Limited is 001-38104.

What is the reporting period for this Form 6-K?

The reporting period for this Form 6-K is the month of September 2024.

Where is Immuron Limited's principal executive office located?

Immuron Limited's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

Filing Stats: 314 words · 1 min read · ~1 pages · Grade level 18.8 · Accepted 2024-09-26 07:00:43

Filing Documents

From the Filing

OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of September 2024 Commission File Number: 001-38104 IMMURON LIMITED (Name of Registrant) Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes No If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- IMMURON LIMITED EXPLANATORY NOTE Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on September 26, 2024 titled: - “Immuron CEO presentation to Emerging Growth Conference” A copy of the Public Notice is attached as an exhibit to this report on Form 6-K. This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. 1 EXHIBITS Exhibit Number Description 99.1 Immuron CEO presentation to Emerging Growth Conference 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IMMURON LIMITED Date: September 26, 2024 By: /s/ Phillip Hains Phillip Hains Company Secretary 3

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing